ARQT - Arcutis Biotherapeutics Stock Climbs After Blockbuster Q1 Results | Benzinga
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) reported its first-quarter financial results after the bell Tuesday. Here's a look at the highlights.
The Details: Arcutis Biotherapeutics reported quarterly earnings of 32 cents per share which beat the analyst consensus estimate of losses of 73 cents.
Quarterly sales clocked in at $49.57 million, beating the analyst consensus estimate of $14.68 million by 237.66% and represented 1,680% increase over sales of $2.78 million from ...